Spruce Biosciences Statistics
Total Valuation
SPRB has a market cap or net worth of $124.47 million. The enterprise value is $45.10 million.
| Market Cap | 124.47M |
| Enterprise Value | 45.10M |
Important Dates
The last earnings date was Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRB has 2.87 million shares outstanding. The number of shares has increased by 242.02% in one year.
| Current Share Class | 2.87M |
| Shares Outstanding | 2.87M |
| Shares Change (YoY) | +242.02% |
| Shares Change (QoQ) | +16.05% |
| Owned by Insiders (%) | 3.45% |
| Owned by Institutions (%) | 49.33% |
| Float | 2.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 8.93 |
| PS Ratio | n/a |
| Forward PS | 1.06 |
| PB Ratio | 1.88 |
| P/TBV Ratio | 1.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.83, with a Debt / Equity ratio of 0.13.
| Current Ratio | 4.83 |
| Quick Ratio | 4.69 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.79 |
Financial Efficiency
Return on equity (ROE) is -187.35% and return on invested capital (ROIC) is -99.69%.
| Return on Equity (ROE) | -187.35% |
| Return on Assets (ROA) | -75.61% |
| Return on Invested Capital (ROIC) | -99.69% |
| Return on Capital Employed (ROCE) | -88.59% |
| Weighted Average Cost of Capital (WACC) | 23.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.69M |
| Employee Count | 25 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.62% in the last 52 weeks. The beta is 3.54, so SPRB's price volatility has been higher than the market average.
| Beta (5Y) | 3.54 |
| 52-Week Price Change | -57.62% |
| 50-Day Moving Average | 47.22 |
| 200-Day Moving Average | 54.07 |
| Relative Strength Index (RSI) | 45.78 |
| Average Volume (20 Days) | 71,930 |
Short Selling Information
The latest short interest is 531,380, so 18.49% of the outstanding shares have been sold short.
| Short Interest | 531,380 |
| Short Previous Month | 522,120 |
| Short % of Shares Out | 18.49% |
| Short % of Float | 26.41% |
| Short Ratio (days to cover) | 6.83 |
Income Statement
| Revenue | n/a |
| Gross Profit | -45.28M |
| Operating Income | -64.88M |
| Pretax Income | -67.15M |
| Net Income | -67.15M |
| EBITDA | -63.25M |
| EBIT | -64.88M |
| Earnings Per Share (EPS) | -$33.82 |
Balance Sheet
The company has $87.69 million in cash and $8.32 million in debt, with a net cash position of $79.37 million or $27.62 per share.
| Cash & Cash Equivalents | 87.69M |
| Total Debt | 8.32M |
| Net Cash | 79.37M |
| Net Cash Per Share | $27.62 |
| Equity (Book Value) | 66.30M |
| Book Value Per Share | 23.07 |
| Working Capital | 71.59M |
Cash Flow
In the last 12 months, operating cash flow was -$51.07 million and capital expenditures -$145,000, giving a free cash flow of -$51.21 million.
| Operating Cash Flow | -51.07M |
| Capital Expenditures | -145,000 |
| Depreciation & Amortization | 1.63M |
| Net Borrowing | 13.36M |
| Free Cash Flow | -51.21M |
| FCF Per Share | -$17.82 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SPRB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -242.02% |
| Shareholder Yield | -242.02% |
| Earnings Yield | -78.10% |
| FCF Yield | -41.14% |
Analyst Forecast
The average price target for SPRB is $147.44, which is 240.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $147.44 |
| Price Target Difference | 240.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on August 7, 2025. It was a reverse split with a ratio of 1:75.
| Last Split Date | Aug 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:75 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |